Stay updated on Pembrolizumab + Carboplatin vs Carboplatin in Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Carboplatin vs Carboplatin in Breast Cancer Clinical Trial page.

Latest updates to the Pembrolizumab + Carboplatin vs Carboplatin in Breast Cancer Clinical Trial page
- Check6 days agoChange DetectedAdded Show glossary and new data fields (Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, Revision: v3.4.0) and removed the corresponding estimated/older fields (Results First Posted (Estimated), Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, Revision: v3.3.4).SummaryDifference0.3%

- Check13 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed, indicating a minor version update to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check35 days agoChange DetectedResults have been posted (2025-12-22) and the study plan was updated to include cross-over (Arm Bx) and a revised enrollment target of 76 participants. The endpoints and translational components are described in greater detail, including DCR, PFS, ORR, irRECIST-based assessments, and tumor biomarker analyses.SummaryDifference3%

- Check43 days agoChange DetectedA consolidated Locations section was added with state sites (California, District of Columbia, Illinois, Indiana, Massachusetts, Pennsylvania, Tennessee) and prior state blocks were removed; a new Revision: v3.3.3 tag was introduced.SummaryDifference0.8%

- Check57 days agoChange DetectedDifference0.1%

- Check64 days agoChange DetectedRevision updated to v3.3.2; the previous revision v3.3.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab + Carboplatin vs Carboplatin in Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Carboplatin vs Carboplatin in Breast Cancer Clinical Trial page.